​
​

NextCure (NXTC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

NextCure Revenue Highlights

00

NextCure Revenue by Period

NextCure Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$22.38M252.58%
2019-12-31$6.35M100.00%
2018-12-31-100.00%
2017-12-31--

NextCure generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

NextCure Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$6.28M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$22.38M1016.11%
2019-12-31$2.00M26.66%
2019-09-30$1.58M12.91%
2019-06-30$1.40M3.32%
2019-03-31$1.36M100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

NextCure generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

NextCure Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
ASMBAssembly Biosciences$7.16M$6.84M
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$727.00K

NXTC Revenue FAQ

What is NextCure’s yearly revenue?

NextCure's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NXTC's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

What is NextCure’s quarterly revenue?

NextCure's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). NXTC's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is NextCure’s revenue growth rate?

NextCure's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.